跳至主要内容
临床试验/NL-OMON45688
NL-OMON45688尚未招募不适用

Diet as add on therapy for active Crohn*s disease - Diet and Crohn*s disease

eids Universitair Medisch Centrum0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • 5.1 Population (base)
  • Patients with active luminal Crohn*s disease
  • 5.2 Inclusion criteria
  • Patients >18 years, active luminal Crohn*s disease localized in colon and/ or terminal ileum, fecal calprotectin (fCAL) > 150 mg/g andSES-CD>5 or calpro >300 mg/g.

排除标准

  • Patients unable or unwilling to provide informed consent, stenosis associated with symptoms, contra-indications to starting biological or immunomodulatory agent. Additionally, the relative Mediterranean diet score will be calculated based on self-reported dietary intake by a food frequency questionnaire to exclude patients already using a Mediterranean-like diet.

研究者

相似试验